marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2024-Q2
hinzugefügt 08.08.2024
4D Molecular Therapeutics Bilanz 2011-2024 | FDMT
Bilanz Jährlich 4D Molecular Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-234 M | -36.2 M | -137 M | -277 M | -49.7 M | -91.8 M | -23.8 M | - | - | - | - | - | - |
Langfristige Schulden |
11.5 M | 13.5 M | 15.2 M | - | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
3.15 M | 2.66 M | 1.23 M | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | 15.2 M | 118 M | 117 M | 41 M | - | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
19 M | 15.7 M | 16.3 M | 16.7 M | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
32.1 M | 30.5 M | 34.4 M | 31.9 M | 131 M | 125 M | 46.9 M | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
273 K | 884 K | 2.6 M | 6.59 M | 5.86 M | 4.91 M | 4.38 M | - | - | - | - | - | - |
Gewinnrücklagen |
-415 M | -314 M | -207 M | -136 M | -79 M | -30 M | -20.5 M | - | - | - | - | - | - |
Vermögenswerte |
340 M | 262 M | 353 M | 288 M | 58.2 M | 97 M | 27.3 M | - | - | - | - | - | - |
Zahlungsmittel |
249 M | 52.4 M | 153 M | 277 M | - | - | - | - | - | - | - | - | - |
Buchwert |
308 M | 231 M | 319 M | 256 M | -73 M | -27.6 M | -19.6 M | - | - | - | - | - | - |
Gesamtes Eigenkapital |
308 M | 231 M | 319 M | 256 M | -73 M | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich 4D Molecular Therapeutics
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
10.5 M | 11 M | 11.5 M | 12 M | 12.5 M | - | 13.5 M | 13.9 M | 14.4 M | 14.8 M | 15.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
31.8 M | 29.3 M | 32.1 M | 31.7 M | 27.4 M | - | 30.5 M | 28.7 M | 30.4 M | 28.9 M | 34.4 M | 16.5 M | 14.3 M | 27.7 M | 31.9 M | 31.9 M | 31.9 M | 31.9 M | 28.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | 273 K | 130 K | 576 K | - | 884 K | 2.21 M | 2.26 M | 2.11 M | 2.6 M | 1.73 M | 3.02 M | 7.09 M | 6.59 M | 6.59 M | 6.59 M | 6.59 M | 5.86 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-483 M | -448 M | -415 M | -383 M | -373 M | - | -314 M | -287 M | -261 M | -233 M | -207 M | -182 M | -160 M | -152 M | -136 M | -136 M | -136 M | -136 M | -79 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
620 M | 630 M | 340 M | 362 M | 353 M | - | 262 M | 280 M | 303 M | 325 M | 353 M | 241 M | 255 M | 270 M | 288 M | 288 M | 288 M | 288 M | 58.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
189 M | 276 M | 249 M | 276 M | 236 M | - | 52.4 M | 108 M | 113 M | 76 M | 153 M | 91 M | 244 M | 260 M | 277 M | 277 M | 277 M | 277 M | 49.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
588 M | 601 M | 308 M | 330 M | 325 M | - | 231 M | 251 M | 273 M | 296 M | 319 M | 224 M | 241 M | 242 M | 256 M | 256 M | 256 M | 256 M | 30 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
588 M | 601 M | 308 M | 330 M | 325 M | 219 M | 231 M | 251 M | 273 M | 296 M | 319 M | 224 M | 241 M | 242 M | 256 M | 256 M | 256 M | 256 M | -73 M | - | - | - | -27.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung